Observational Study of Fetal Heartbeat Characteristics In Pregnant Women Diagnosed With Covid -19 Treated At The Regional Maternal And Child Teaching Hospital El Carmen - Huancayo, 2020

  IJETT-book-cover  International Journal of Engineering Trends and Technology (IJETT)          
  
© 2021 by IJETT Journal
Volume-69 Issue-4
Year of Publication : 2021
Authors : Lina Cárdenas-Pineda, Nilda, Cantorin-Aliaga, Leonardo, Leyva-Yataco, Gabriela, Ordoñez- Ccora, Claris, Pérez-Venegas, Zelmira, Flor De la Cruz Ramos, Alicia Alva Mantari
DOI :  10.14445/22315381/IJETT-V69I4P216

Citation 

MLA Style: Lina Cárdenas-Pineda, Nilda, Cantorin-Aliaga, Leonardo, Leyva-Yataco, Gabriela, Ordoñez- Ccora, Claris, Pérez-Venegas, Zelmira, Flor De la Cruz Ramos, Alicia Alva Mantari  "Observational Study of Fetal Heartbeat Characteristics In Pregnant Women Diagnosed With Covid -19 Treated At The Regional Maternal And Child Teaching Hospital El Carmen - Huancayo, 2020" International Journal of Engineering Trends and Technology 69.4(2021):107-117. 

APA Style:Lina Cárdenas-Pineda, Nilda, Cantorin-Aliaga, Leonardo, Leyva-Yataco, Gabriela, Ordoñez- Ccora, Claris, Pérez-Venegas, Zelmira, Flor De la Cruz Ramos, Alicia Alva Mantari. Observational Study of Fetal Heartbeat Characteristics In Pregnant Women Diagnosed With Covid -19 Treated At The Regional Maternal And Child Teaching Hospital El Carmen - Huancayo, 2020  International Journal of Engineering Trends and Technology, 69(4),107-117.

Abstract
This quantitative exploratory study is aimed at characterizing the fetal heartbeat (FHC) in pregnant women diagnosed with COVID - 19 treated at the Regional Maternal and Child Teaching Hospital El Carmen - Huancayo, 2020. Methodology: Observational, prospective, cross-sectional, descriptive, in 31 pregnant women, an observation card was used along with parameters of Fisher. Results: Slight COVID - 19 was found in the 31 pregnant women, 64.52% of whom were between 20 and 34 years old, while 93.55% were from the urban area, 90.32% were housewives, 48.39% were primiparous, and 38.71% were multiparous. The mean temperature was 36.9, blood pressure 111/71 mmHg, and saturation was 92.81%, baseline 90.32% was normal, tachycardia presented in 9.68%, variability was absent in 25.81%, minimal in 35.48%, and normal in 38.71%, no accelerations were observed in 25.81% and 1 - 4 accelerations in 51.61% and ? 5 in 22. 58%, and decelerations of type III in 16.13%. When analyzing comorbidity vs no comorbidity, tachycardia was found in 11.11% vs 9.09%, absent variability 22.22% vs 27.27%, minimum variability 22.22% vs 40.91%, absent accelerations in 11.11% vs 31.82%, and decelerations of type III 11.11% vs 13.64%. Conclusions: Tachycardia was found in 9.68%, variability absent, and no accelerations in 25.81%, which indicates that a little more than 25% present signs of fetal hypoxia; therefore, antepartum and intrapartum monitoring is necessary.

Reference
[1] WHO Director-General’s opening remarks at the media briefing on COVID-19 - (2020)., https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed Feb. 15, (2021).
[2] Brote de enfermedad por el Coronavirus (COVID-19) - OPS/OMS | Organización Panamericana de la Salud., https://www.paho.org/es/temas/coronavirus/brote-enfermedad-por-coronavirus-covid-19 (accessed Feb. 01, 2021).
[3] Coronavirus disease (COVID-19) – World Health Organization., https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed Feb. 15, (2021).
[4] Y. Liu, H. Chen, K. Tang, and Y. Guo., Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy, J. Infect.,(2020), doi: 10.1016/j.jinf.2020.02.028.
[5] C. Nelson-Piercy, I. Vlaev, K. Harris, and R. Fischer-Betz, “What factors could influence physicians’ management of women of childbearing age with chronic inflammatory disease? A systematic review of behavioral determinants of clinical inertia, BMC Health Serv. Res., 19(2019) doi: 10.1186/s12913-019-4693-x.
[6] P. Dashraath et al., Coronavirus disease 2019 (COVID-19) pandemic, and pregnancy Am. J. Obstet. Gynecol., 222(6)(2020) 521–531, doi: 10.1016/j.ajog.2020.03.021.
[7] S. Ellington, Characteristics of Women of Reproductive Age with laboratory-confirmed SARS-CoV-2 Infection by Pregnancy Status — the United States, (2020), MMWR Morb. Mortal. Wkly. Rep., 69(2020), doi: 10.15585/mmwr.mm6925a1.
[8] F. Elshafeey et al., A systematic scoping review of COVID-19 during pregnancy and childbirth, Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet., 150(1) 47–52, Jul. 2020, doi: 10.1002/ijgo.13182.
[9] S. Goodacre et al., Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modeling., Health Technol. Assess. Winch. Engl., 22(47)(2018) 1–230, doi: 10.3310/hta22470.
[10] B. J. F. Huntley, E. S. Huntley, D. Di Mascio, T. Chen, V. Berghella, and S. P. Chauhan, Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review, Obstet. Gynecol., 136(2)(2020) 303–312 doi: 10.1097/AOG.0000000000004010.
[11] Prefacio | Gomella Neonatología: Tratamiento, procedimientos, problemas durante la guardia, enfermedades y fármacos, 8e | AccessMedicina | McGraw-Hill Medical., https://accessmedicina.mhmedical.com/content.aspx?bookid=2928&sectionid=246260430 (accessed Feb. 15, 2021).
[12] R. M. Grivell, Z. Alfirevic, G. M. Gyte, and D. Devane, Antenatal cardiotocography for fetal assessment, Cochrane Database Syst. Rev., 9, (2015), doi: 10.1002/14651858.CD007863.pub4.
[13] C. A. Ducsay, R. Goyal, W. J. Pearce, S. Wilson, X.-Q. Hu, and L. Zhang, Gestational Hypoxia and Developmental Plasticity, Physiol. Rev., 98(3)(2018) 1241–1334, doi: 10.1152/physrev.00043.2017.
[14] P. Tang, J. Wang, and Y. Song, Characteristics and pregnancy outcomes of patients with severe pneumonia complicating pregnancy: a retrospective study of 12 cases and a literature review, BMC Pregnancy Childbirth, 18(1)(2018) 434, doi: 10.1186/s12884-018-2070-0.
[15] O. Martínez-López et al., Frecuencia cardíaca fetal en pacientes con diagnóstico de diabetes pregestacional y gestacional, Clínica E Investig. En Ginecol. Obstet., 32(1)(2005) 19–26, J doi: 10.1016/S0210-573X(05)73468-7.
[16] G. Romero-Salinas, G. Oropeza, C. Castillo, A. Guerrero, G. Barrientos, and M. Torres, El modelo de la frecuencia cardíaca fetal en embarazadas con diagnóstico de anemia ferropénica, Clínica E Investig. En Ginecol. Obstet., 30(2)(2003) 42–52, doi: 10.1016/S0210-573X(03)77229-3.
[17] G. Romero-Salinas et al., La frecuencia cardíaca fetal en pacientes con diagnóstico de preeclampsia leve y grave, Clínica E Investig. En Ginecol. Obstet., 37(1)(2010) 2–13 doi: 10.1016/j.gine.2009.02.003.
[18] G. Romero-Salinas et al., La frecuencia cardiaca fetal en embarazadas adolescentes, Clínica E Investig. En Ginecol. Obstet., 38(6)(2011) 222–228.
[19] Williams Obstetricia 24o Ed. por Cunningham, F. Gary - 9786071512772 - Journal, Ediciones Journal - libros profesionales para lasalud.https://www.edicionesjournal.com/Papel/9786071512772/Williams+Obstetricia+24o+Ed (accessed Feb. 15, 2021).
[20] V. A. Hernández et al., Principios de medicina materno fetal. Santander, (2018).
[21] O. F. Dueñas-García and M. Diaz-Sotomayor, Controversias e historia del monitoreo cardiaco fetal, Rev. Investig. Clínica, 63(6)(2011) 659–663.
[22] L. C. Roura, Obstetricia y medicina materno-fetal. Ed. Médica Panamericana, (2007).
[23] L. C. i Roura et al., Tratado de ginecología y obstetricia. (2014).
[24] J. E. Martín López, C. Beltrán Calvo, and R. Rodríguez López, “Efectividad de la electrocardiografía fetal frente a la pulsioximetría para la determinación del bienestar fetal, Clínica E Investig. En Ginecol. Obstet., 42(4)(2015) 157–164 doi: 10.1016/j.gine.2014.04.002.
[25] Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention, [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China], Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi, 41(2)(2020) 145–151, doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
[26] N. Chen et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, The Lancet, 395(10223)(2020) 507–513, doi: 10.1016/S0140-6736(20) 30211-7.
[27] C. Huang et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet, 395(10223)(2020) 497–506, doi: 10.1016/S0140-6736(20)30183-5.
[28] F. Jiang, L. Deng, L. Zhang, Y. Cai, C. W. Cheung, and Z. Xia, Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19), J. Gen. Intern. Med., 35(5)(2020) 1545–1549, doi: 10.1007/s11606-020-05762-w.
[29] C. Rothe et al., Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany, N. Engl. J. Med., 382(10)(2020) 970–971 doi: 10.1056/NEJMc2001468.
[30] Y. Jin et al., Virology, Epidemiology, Pathogenesis, and Control of COVID-19, Viruses, 12(4)(2020), doi: 10.3390/v12040372.
[31] T. Singhal, A Review of Coronavirus Disease-2019 (COVID-19), Indian J. Pediatr., 87(4)(2020) 281–286 doi: 10.1007/s12098-020-03263-6.
[32] Prevención, diagnóstico y tratamiento de personas afectadas por COVID-19 en el Perú.” https://www.gob.pe/institucion/minsa/informes-publicaciones/473587-prevencion-diagnostico-y-tratamiento-de-personas-afectadas-por-covid-19-en-el-peru (accessed Feb. 15, 2021).
[33] H. Akhtar, C. Patel, E. Abuelgasim, and A. Harky, COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review, Gynecol. Obstet. Invest., 85(4)(2020) 295–306, doi: 10.1159/000509290.
[34] V. Smith et al., Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review, PLOS ONE, 15(6)(2020) e0234187, doi: 10.1371/journal.pone.0234187.
[35] LUIS FERNANDO CORREA SERNA - MINISTERIO DE SALUD Y PROTECCION SOCIAL - SIGEP - Función Pública., https://www.funcionpublica.gov.co/web/sigep/hdv/-/directorio/M101065-8006-4/view (accessed Feb. 15, 2021).
[36] D. J. Supo and M. H. Zacarías, METODOLOGÍA DE LA INVESTIGACIÓN CIENTÍFICA: Para las Ciencias de la Salud y las Ciencias Sociales. 2020.

Keywords
COVID - 19, Fetal Monitoring, Oxygen Saturation